Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
Product to be stored at room temperature
Update 48 JongN
This combination includes four peptides that have been studied for their potential effects on a variety of biological processes
Caractersticas Principales
Multi-peptide formulations are often evaluated in qualified laboratory environments where researchers are studying peptide interactions, molecular signaling pathways, protein expression, extracellular matrix biology, peptide chemistry, and analytical peptide characterization